Pleural Malignant Mesothelioma — Trials

Pleural Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05425576	OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition	not yet recruiting	Phase 2	63	Oncotelic Inc.INDUSTRY	1	Mar 15, 2024	clinicaltrials

Data updated 22 days agoSource updated Mar 15, 2024source: clinicaltrials